WorleyParsons awarded Evonik contract
Evonik Industries has awarded WorleyParsons a contract for the detail engineering, procurement support and construction management on the building of world scale plants for the production of Isophorone and Isophorone diamine. The plants will be located in Shanghai, China, with a total capacity of 50 kt./a. Start of the production is scheduled for the first quarter of 2014.
"We are going to extend our global production network into Asia, which is only possible with a world-wide acting partner. For the successful implementation within our ambitious timeline we found the right partner in WorleyParsons", says Dr. Udo Kowalczik, Head of Production and Technology at Evonik’s Coatings & Additives Business Unit.
Evonik currently produces isophorone chemicals in Herne and Marl (Germany), in Mobile, Alabama (USA) as well as Antwerp (Belgium).
Isophorone and isophorone diamine are important components in the production of industrial flooring as well as paints and coatings, for example. They are also used in the high-growth area of high-performance composite materials and in chemical synthesis. Evonik distributes these products worldwide under the trademarks of VESTASOL® and VESTAMIN®.
WorleyParsons is a leading provider of professional services to the energy, resource, and complex process industries. The company’s services cover the full asset spectrum both in size and lifecycle from the creation of new assets to services that sustain and enhance the value of operating assets.
Evonik, the creative industrial group from Germany, is one of the world leaders
in specialty chemicals. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. In 2010 about 80 percent of the Group’s chemicals sales came from activities where it ranks among the market leaders. Evonik benefits specifically from its innovative prowess and integrated technology platforms.
Evonik is active in over 100 countries around the world. In fiscal 2010 more than 34,000 employees generated sales of around €13.3 billion and an operating profit (EBITDA) of about €2.4 billion.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.